Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Study found that certain genetic variants in the IL1RN gene significantly reduce COVID-19-related inflammation and mortality in patients, with notable improvements observed in older men carrying specific single-nucleotide variants.

What to know about Sarepta’s upcoming data on its Duchenne gene therapy

In the next few weeks, Sarepta Therapeutics will release new data that could change the future of the company and the lives of thousands of

October 30, 2023

Study reveals liver-brain communication as key to managing circadian eating patterns and obesity

This study uncovers the hepatic vagal nerve’s influence on circadian food intake, presenting new avenues for obesity treatment through targeted interventions.

November 11, 2024

PRECISIS GmbH celebrates Win at the Innovation Award of the Federal State Baden-Württemberg 2023 – Biotech Investments

Issuer: PRECISIS GmbH / Key word(s): Miscellaneous 22.11.2023 / 14:57 CET/CEST The issuer is solely responsible for the content of this announcement. Heidelberg, November 22nd

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.